Quality of life of carpal tunnel syndrome with non operative treatment: cohort study

Merlin P. Kastilong; Karema Winifred; Sekplin A. S. Sekeon

doi:10.18203/2320-6012.ijrms20202886

Authors

Merlin P. Kastilong Department of Neurology, Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia
Karema Winifred Department of Neurology, Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia
Sekplin A. S. Sekeon Department of Neurology, Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia

DOI:

https://doi.org/10.18203/2320-6012.ijrms20202886

Keywords:

Carpal tunnel syndrome, Non operative treatment, Quality of life

Abstract

Background: Carpal tunnel syndrome (CTS) is the most common peripheral neuropathy entrapment and it interferes with the quality of life. Treatment for CTS can be divided into operative and non-operative treatment. Our objective was to compare the quality of life and pain intensity in a patient with CTS after oral treatment and local corticosteroid injection (LCI).

Methods: A prospective cohort study was conducted in 18-65 years patients with CTS. Primary outcome was to compare the quality of life post oral treatment (NSAIDs, oral steroids, gabapentin) and LCI using the Short Form-36 questionnaire. Secondary output was to compare pain intensity using Numeric Rating Scale (NRS). Mann-Whitney and independent t-test were used to assess the comparison between the treatment.

Results: Sixty CTS patients were included in this study, with 32 patients (53.33%) assigned to LCI. After observation one month, statistical analysis showed that LCI improved the quality of life better than oral in physical function and bodily pain components (p = 0.036 and p = 0.047). Injection treatment decreased pain intensity more than oral not statistically significant after 14 days (p=0.087), but was significant after one month (p=0.002).

Conclusions: Local corticosteroid injection improved quality of life and decreased pain intensity better than oral treatment after one month.

Metrics

Metrics Loading ...

References

Ibrahim I, Khan W, Goddard N, Smitham P. Carpal Tunnel Syndrome: a review of the recent literature. Open Orthopaed J. 2012;6:69-76.

Ghasemi-rad M. A handy review of carpal tunnel syndrome: From anatomy to diagnosis and treatment. World J Radiol. 2014;6(6):284.

Wolska J, Wolski D, Bienko M, Radzki R. life quality of patients with carpal tunnel syndrome. Eur J Clin Exp Med. 2018;16(3):217-23.

Wipperman J, Goerl K. Carpal Tunnel Syndrome: Diagnosis and Management. Am Fam Physician. 2016;94(12):993-9.

Waldman SD, editor. Pain management. Edisi ke-2. Philadelphia: Elsevier/Saunders; 2011.

Kurniawan S. Buku ajar saraf perifer. Edisi pertama. Malang: Universitas Brawijaya Press. 2012.

Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. 2008. Available at: http://www.thecochranelibrary.com. Accessed 20 December 2019.

Gurcay E, Unlu E, Gurcay A, Tuncay R, Cakci A. Evaluation of the effect of local corticosteroid injection and anti-inflammatory medication in carpal tunnel syndrome. Scott Med J. 2009;54(1):4-6.

Erdemoglu AK. The efficacy and safety of gabapentin in carpal tunnel patients: Open label trial. Neurol India. 2009;57(3):300.

Padua L, Coraci D, Erra C, Pazzaglia C, Paolasso I, Loreti C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016 Nov;15(12):1273-84.

Wolny T, Linek P, Saulicz E. Overall health status in patients with mild to moderate carpal tunnel syndrome: A case-control study. J Hand Ther. 2017;30(3):293-8.

Jarvik JG, Comstock BA, Kliot M, Turner JA, Chan L, Heagerty PJ, et al. Surgery versus non-surgical therapy for carpal tunnel syndrome: a randomised parallel-group trial. Lancet. 2009;374(9695):1074-81.

Celiker R, Arslan S, Inanici F. Corticosteroid injection vs. nonsteroidal antiinflammatory drug and splinting in carpal tunnel syndrome. Am J Phys Med Rehabil. 2002;81(3):182-6.

Chang MH, Ger LP, Hsieh PF, Huang SY. A randomised clinical trial of oral steroids in the treatment of carpal tunnel syndrome: a long term follow up. J Neurol, Neurosurg Psychiatry. 2002 Dec 1;73(6):710-4.

Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A. The Efficacy of 100 and 300 mg Gabapentin in the Treatment of Carpal Tunnel Syndrome. Iran J Pharm Res IJPR. 2015;14(4):1275-80.

Wong SM, Hui AC, Tang A, Ho PC, Hung LK, Wong KS, et al. Local vs systemic corticosteroids in the treatment of carpal tunnel syndrome. Neurol. 2001;56(11):1565-7.

Katz JN, Keller RB, Simmons BP, Rogers WD, Bessette L, Fossel AH, et al. Maine carpal tunnel study: Outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort. J Hand Surg. 1998;23(4):697-710.

Lawry GV, Kreder HJ, Hawker G, Jerome D. Fam’s Musculoskeletal Examination and Joint Injection Techniques: Expert Consult. London: Elsevier Health Sciences; 2010.

Türck D, Busch U, Heinzel G, Narjes H. Clinical pharmacokinetics of meloxicam. Arzneimittel Forschung. 1997;47(3):253-8.

Tacca M, Colucci R, Fornai M, Blandizzi C. Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug. Clin Drug Invest. 2002;22(12):799-818.

Brunton LL, Knollmann BC, Hilal-Dandan R, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. Thirteenth edition. New York: McGraw Hill Medical; 2018.

Herskovitz S, Berger AR, Lipton RB. Low-dose, short-term oral prednisone in the treatment of carpal tunnel syndrome. Neurol. 1995;45(10):1923-5.